Remarkable response to ceritinib and brigatinib in an anaplastic lymphoma kinase-rearranged anaplastic thyroid carcinoma previously treated with crizotinib
Nom du journal : Thyroid
Année : 2019
Volume : doi: 10.1089/thy.2019.0202 [Epub ahead of print]